Lindicy L. Alves
Belo Horizonte, MG, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Efficacy of topical hydrophilic gel of paromomycin combined with systemic or locally administered leishmanicidal drugs for treatment of experimental leishmaniasis caused by Leishmania (Viannia) braziliensis.
Journal: The Journal of antimicrobial chemotherapy
Published: May 06, 2025
Impact of age and immune status on the accuracy of rapid diagnostic tests for visceral leishmaniasis in Brazil.
Journal: PLoS neglected tropical diseases
Published: October 18, 2024
Can letrozole be repurposed for the treatment of visceral leishmaniasis?
Journal: Antimicrobial agents and chemotherapy
Published: October 10, 2024
Local amphotericin B therapy for Cutaneous Leishmaniasis: A systematic review.
Journal: PLoS neglected tropical diseases
Published: June 21, 2023
The cure rate after different treatments for mucosal leishmaniasis in the Americas: A systematic review.
Journal: PLoS neglected tropical diseases
Published: July 28, 2022
Performance differences among commercially available antigen rapid tests for COVID-19 in Brazil.
Journal: PloS one
Published: March 15, 2022
Diagnostic performance of commercially available COVID-19 serology tests in Brazil.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: August 05, 2020
A new nanoemulsion formulation improves antileishmanial activity and reduces toxicity of amphotericin B.
Journal: Journal of drug targeting
Published: October 19, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026